Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

823 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy applied.
Fischer T, Neubauer A, Mohm J, Huhn D, Busemann C, Link H, Arseniev L, Büssing B, Novotny J, Ganser A, Duyster J, Bunjes D, Westermeier T, Flohr T, Desprès D, Gamm H, Decker J, Derigs G, Aulitzky W, Huber C. Fischer T, et al. Among authors: link h. Ann Hematol. 1998 Jul-Aug;77(1-2):21-6. doi: 10.1007/s002770050406. Ann Hematol. 1998. PMID: 9760148 Clinical Trial.
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML.
Fischer T, Neubauer A, Mohm J, Huhn D, Busemann C, Link H, Arseniev L, Büssing B, Novotny J, Ganser A, Duyster J, Bunjes D, Kreiter S, Aulitzky W, Hehlmann R, Huber C. Fischer T, et al. Among authors: link h. Bone Marrow Transplant. 1998 May;21(10):1029-36. doi: 10.1038/sj.bmt.1701229. Bone Marrow Transplant. 1998. PMID: 9632277
Transplantation of allogeneic CD34+ blood cells.
Link H, Arseniev L, Bähre O, Kadar JG, Diedrich H, Poliwoda H. Link H, et al. Blood. 1996 Jun 1;87(11):4903-9. Blood. 1996. PMID: 8639865 Free article. Clinical Trial.
Stem cell mobilization in normal donors.
Arseniev L, Hertenstein B, Link H, Ganser A, Serke S. Arseniev L, et al. Among authors: link h. J Hematother. 1998 Feb;7(1):5-7. doi: 10.1089/scd.1.1998.7.5. J Hematother. 1998. PMID: 9507376 No abstract available.
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
Proetel U, Pletsch N, Lauseker M, Müller MC, Hanfstein B, Krause SW, Kalmanti L, Schreiber A, Heim D, Baerlocher GM, Hofmann WK, Lange E, Einsele H, Wernli M, Kremers S, Schlag R, Müller L, Hänel M, Link H, Hertenstein B, Pfirrman M, Hochhaus A, Hasford J, Hehlmann R, Saußele S; German Chronic Myeloid Leukemia Study Group; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK). Proetel U, et al. Among authors: link h. Ann Hematol. 2014 Jul;93(7):1167-76. doi: 10.1007/s00277-014-2041-0. Ann Hematol. 2014. PMID: 24658964 Free PMC article. Clinical Trial.
Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study.
Kirschey S, Flohr T, Wolf HH, Frickhofen N, Gramatzki M, Link H, Basara N, Peter N, Meyer RG, Schmitz N, Weidmann E, Banat A, Schulz A, Kolbe K, Derigs G, Theobald M, Hess G. Kirschey S, et al. Among authors: link h. Br J Haematol. 2015 Mar;168(6):824-34. doi: 10.1111/bjh.13234. Epub 2014 Dec 28. Br J Haematol. 2015. PMID: 25546611 Free article. Clinical Trial.
823 results